What is the ICD-10 (International Classification of Diseases, 10th Revision) code for STD (Sexually Transmitted Disease) screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Code for STD Screening

For routine STD screening in asymptomatic individuals, use ICD-10 code Z11.3 (Encounter for screening for infections with a predominantly sexual mode of transmission).

Primary Screening Code

  • Z11.3 is the appropriate ICD-10 code for encounters specifically for screening for sexually transmitted infections in asymptomatic patients 1
  • This code applies when the patient presents without symptoms and the purpose is preventive screening rather than diagnostic evaluation 2

Related Codes for High-Risk Encounters

When documenting encounters that indicate increased risk for STI/HIV, additional codes may be relevant:

  • Z20.2: Contact with and exposure to infections with a predominantly sexual mode of transmission 3
  • Z72.52: High-risk homosexual behavior 3
  • Z72.53: High-risk bisexual behavior 3
  • Z20.6: Contact with and exposure to HIV 3
  • Z29.81: Encounter for HIV pre-exposure prophylaxis 3

Important Clinical Context

The distinction between screening and diagnostic testing is critical for proper coding:

  • Screening codes (Z11.3) apply only to asymptomatic individuals seeking preventive services 2
  • Once symptoms are present, testing becomes diagnostic and requires disease-specific codes 2
  • Disease-specific ICD-10 codes (such as A74.9 for chlamydia or A54.9 for gonorrhea) should only be used when infection is confirmed or strongly suspected, not for screening 3, 4

Common Coding Pitfalls to Avoid

  • Do not confuse pelvic examination with STD screening: Many patients erroneously believe a Pap test was performed during a routine pelvic exam when it was not 1, 5
  • Pap tests are NOT STD screening tests: The CDC explicitly states that Pap tests should not be considered screening tests for STDs 1
  • Avoid using unspecified STI codes (A64) for screening: This code has poor positive predictive value (32.0%) and should not be used for screening encounters 4
  • Do not use disease-specific codes without laboratory confirmation: ICD-10 codes for specific STIs (chlamydia A74.9, gonorrhea A54.9) have high positive predictive values (87.6% and 85.0% respectively) but should only be used when infection is documented 4

Screening Recommendations by Population

The following populations should receive routine STD screening, all coded with Z11.3:

  • All sexually active females aged <25 years should be screened for chlamydia and gonorrhea at least annually 1
  • Young sexually active men should be screened routinely, particularly in settings where prevalence is ≥2% 1
  • Persons entering correctional facilities should be screened for syphilis, gonorrhea, and chlamydia 1
  • Adolescents in institutional settings (schools, Job Corps, community programs) should be screened when prevalence is ≥2% 1

Documentation Considerations

  • Administrative data analysis shows that before specific doxy PEP recommendations, most encounters for potentially eligible patients were coded broadly, with Z20.2 being the most common code (78.2% of high-risk encounters) 3
  • When doxycycline is prescribed for STI treatment (not screening), the most common associated codes include symptoms of genitourinary system (R30-R39, 28.7%) and diseases of urinary system (N30-N39, 9.9%) 3
  • Laboratory confirmation is essential for accurate disease-specific coding, as ICD-10 codes alone have low sensitivity (10.6% for chlamydia, 9.7% for gonorrhea) without laboratory results 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.